Literature DB >> 26942072

Hyperthermic intra-peritoneal chemotherapy and anticancer immune response.

Barbara Zunino1, Jean-Ehrland Ricci1.   

Abstract

Peritoneal carcinomatosis (PC) is a metastatic disease of primary tumors localized in the abdomen. Although this disease is considered a terminal condition, recent treatments combining surgery with heated intra-peritoneal chemotherapy (HIPEC) significantly increase patient survival. We have determined that the protective effect of HIPEC is partially linked to the induction of an efficient anticancer immune response.

Entities:  

Keywords:  DAMPs; HIPEC; HSP90; anticancer immune response; peritoneal carcinomatosis

Year:  2015        PMID： 26942072      PMCID： PMC4760280          DOI： 10.1080/2162402X.2015.1060392

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  9 in total

1.  Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90.

Authors:  B Zunino; C Rubio-Patiño; E Villa; O Meynet; E Proics; A Cornille; S Pommier; L Mondragón; J Chiche; J-M Bereder; M Carles; J-E Ricci
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

2.  Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

Authors:  Radek Spisek; Anna Charalambous; Amitabha Mazumder; David H Vesole; Sundar Jagannath; Madhav V Dhodapkar
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

3.  Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model.

Authors:  Y L B Klaver; T Hendriks; R M L M Lomme; H J T Rutten; R P Bleichrodt; I H J T de Hingh
Journal:  Br J Surg       Date:  2010-08-30       Impact factor: 6.939

Review 4.  Immunogenic cell death in cancer therapy.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Oliver Kepp; Laurence Zitvogel
Journal:  Annu Rev Immunol       Date:  2012-11-12       Impact factor: 28.527

Review 5.  Update on Hsp90 inhibitors in clinical trial.

Authors:  Y S Kim; S V Alarcon; S Lee; M-J Lee; G Giaccone; L Neckers; J B Trepel
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

6.  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Authors:  Dominique Elias; Jérémie H Lefevre; Julie Chevalier; Antoine Brouquet; Frédéric Marchal; Jean-Marc Classe; Gwenaël Ferron; Jean-Marc Guilloit; Pierre Meeus; Diane Goéré; Julia Bonastre
Journal:  J Clin Oncol       Date:  2008-12-22       Impact factor: 44.544

Review 7.  Consensus guidelines for the detection of immunogenic cell death.

Authors:  Oliver Kepp; Laura Senovilla; Ilio Vitale; Erika Vacchelli; Sandy Adjemian; Patrizia Agostinis; Lionel Apetoh; Fernando Aranda; Vincenzo Barnaba; Norma Bloy; Laura Bracci; Karine Breckpot; David Brough; Aitziber Buqué; Maria G Castro; Mara Cirone; Maria I Colombo; Isabelle Cremer; Sandra Demaria; Luciana Dini; Aristides G Eliopoulos; Alberto Faggioni; Silvia C Formenti; Jitka Fučíková; Lucia Gabriele; Udo S Gaipl; Jérôme Galon; Abhishek Garg; François Ghiringhelli; Nathalia A Giese; Zong Sheng Guo; Akseli Hemminki; Martin Herrmann; James W Hodge; Stefan Holdenrieder; Jamie Honeychurch; Hong-Min Hu; Xing Huang; Tim M Illidge; Koji Kono; Mladen Korbelik; Dmitri V Krysko; Sherene Loi; Pedro R Lowenstein; Enrico Lugli; Yuting Ma; Frank Madeo; Angelo A Manfredi; Isabelle Martins; Domenico Mavilio; Laurie Menger; Nicolò Merendino; Michael Michaud; Gregoire Mignot; Karen L Mossman; Gabriele Multhoff; Rudolf Oehler; Fabio Palombo; Theocharis Panaretakis; Jonathan Pol; Enrico Proietti; Jean-Ehrland Ricci; Chiara Riganti; Patrizia Rovere-Querini; Anna Rubartelli; Antonella Sistigu; Mark J Smyth; Juergen Sonnemann; Radek Spisek; John Stagg; Abdul Qader Sukkurwala; Eric Tartour; Andrew Thorburn; Stephen H Thorne; Peter Vandenabeele; Francesca Velotti; Samuel T Workenhe; Haining Yang; Wei-Xing Zong; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-13       Impact factor: 8.110

8.  The role of heat shock proteins in antigen cross presentation.

Authors:  Ayesha Murshid; Jianlin Gong; Stuart K Calderwood
Journal:  Front Immunol       Date:  2012-03-30       Impact factor: 7.561

9.  Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab.

Authors:  Diane Goéré; Nathalie Gras-Chaput; Anne Aupérin; Caroline Flament; Christophe Mariette; Olivier Glehen; Laurence Zitvogel; Dominique Elias
Journal:  BMC Cancer       Date:  2014-03-04       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.